Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. 11 March 2020. Nita Lowey.

Executive Summary

An $8.3bn "Coronavirus Preparedness and Response Supplemental" funding act, approved by US Congress and signed into law on 6 March, will assist efforts by US federal and local agencies to fight the coronavirus. See what House Appropriations panel chair Nita Lowey, D-NY, said about it here.

“With the recently enacted $8.3bn emergency supplemental, the federal government can aid state and local health departments in mitigating the extent of the virus.” – Rep. Nita Lowey, panel chair, House Appropriations Committee

Click here for a free trial of Medtech Insight

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT126370

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel